Biocept Accounts Payables 2011-2026 | BIOC

Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.

Main types of accounts payable

Type of liability	Example
To suppliers and contractors	Goods received but not yet paid for
Taxes and fees	VAT, income tax, etc., not paid on time
Salaries	Employee wages not paid
To budgets	Insurance contributions to funds not paid
To founders	Founders provided borrowed funds
To banks	Overdue loan payments
Other	Fines, penalties, forfeits, customer prepayments, etc.

Impact on the company's financial performance

Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios
Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence
Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals)
Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated

Annual Accounts Payables Biocept

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.52 M	7.25 M	8.36 M	2.01 M	2.04 M	1.27 M	960 K	633 K	641 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
8.36 M	633 K	2.74 M

Quarterly Accounts Payables Biocept

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.47 M	1.53 M	1.52 M	3.04 M	4.83 M	8.08 M	7.25 M	7.14 M	5.71 M	7.3 M	8.37 M	8.36 M	8.36 M	8.36 M	2.01 M	2.01 M	2.01 M	2.01 M	2.04 M	2.04 M	2.04 M	2.04 M	1.27 M	1.27 M	1.27 M	1.27 M	960 K	960 K	960 K	960 K	633 K	633 K	633 K	633 K	641 K	641 K	641 K	641 K	1.54 M	1.54 M	1.54 M	1.54 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
8.37 M	633 K	2.8 M

Accounts Payables of other stocks in the Diagnostics research industry

Issuer	Accounts Payables	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	1.38 M	-	-8.98 %	$ 14.8 K	USA
Heska Corporation HSKA	16.4 M	-	-	$ 1.31 B	USA
Celcuity CELC	6.41 M	$ 89.18	-3.56 %	$ 4.17 B	USA
Akumin AKU	36.6 M	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	1.88 M	$ 5.14	-10.76 %	$ 6.84 M	USA
Fulgent Genetics FLGT	18.7 M	$ 19.15	-1.82 %	$ 589 M	USA
Castle Biosciences CSTL	18.7 M	$ 21.36	-1.13 %	$ 619 M	USA
Aspira Women's Health AWH	1.24 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	4.84 M	-	-61.36 %	$ 2.46 M	USA
Guardant Health GH	54.4 M	$ 127.58	-4.12 %	$ 16 B	USA
Interpace Biosciences IDXG	983 K	$ 1.79	2.29 %	$ 7.92 M	USA
Illumina ILMN	240 M	$ 162.64	-3.23 %	$ 25.2 B	USA
CareDx, Inc CDNA	9.99 M	$ 22.39	-3.16 %	$ 1.19 B	USA
Chembio Diagnostics CEMI	3.34 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	790 K	-	-	$ 9.42 M	Israel
ICON Public Limited Company ICLR	192 M	$ 149.96	-1.86 %	$ 11.8 B	Irlanda
HTG Molecular Diagnostics HTGM	1.16 M	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	42.9 M	$ 102.59	-0.22 %	$ 6.92 B	USA
Global Cord Blood Corporation CO	8.33 M	-	-	$ 399 M	China
DermTech DMTK	1.48 M	-	-11.32 %	$ 2.94 M	USA
NeoGenomics NEO	23.1 M	$ 10.96	-3.14 %	$ 1.4 B	USA
Charles River Laboratories International CRL	149 M	$ 183.85	-1.06 %	$ 9.11 B	USA
Natera NTRA	33.2 M	$ 218.2	-1.76 %	$ 29.8 B	USA
Pacific Biosciences of California PACB	20.8 M	$ 1.46	-10.74 %	$ 438 M	USA
Medpace Holdings MEDP	28.1 M	$ 455.55	-0.68 %	$ 13.1 B	USA
Mettler-Toledo International MTD	267 M	$ 1 155.01	-2.16 %	$ 23.8 B	Schweiz
Exact Sciences Corporation EXAS	176 M	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	30 M	$ 4.64	-0.96 %	$ 430 M	USA
National Research Corporation NRC	1.17 M	$ 19.52	-1.14 %	$ 437 M	USA
Personalis PSNL	13 M	$ 11.02	-8.93 %	$ 983 M	USA
Senseonics Holdings SENS	4.06 M	$ 6.7	-4.49 %	$ 280 M	USA
QIAGEN N.V. QGEN	72.7 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	12.4 M	-	-	$ 2.69 B	USA
Biomerica BMRA	295 K	$ 2.21	2.79 %	$ 5.08 M	USA
Laboratory Corporation of America Holdings LH	841 M	$ 265.31	1.61 %	$ 22.1 B	USA
Twist Bioscience Corporation TWST	11.1 M	$ 69.92	-5.43 %	$ 4.18 B	USA
Thermo Fisher Scientific TMO	3.62 B	$ 474.37	-1.6 %	$ 179 B	USA
Waters Corporation WAT	104 M	$ 366.13	-2.74 %	$ 21.8 B	USA
Neogen Corporation NEOG	79.6 M	$ 8.99	-1.48 %	$ 1.95 B	USA
Quest Diagnostics Incorporated DGX	307 M	$ 200.67	2.3 %	$ 22.3 B	USA